Literature DB >> 10852129

Diverse functions of protease receptor tissue factor in inflammation and metastasis.

W Ruf1, E G Fischer, H Y Huang, Y Miyagi, I Ott, M Riewald, B M Mueller.   

Abstract

Accumulating evidence suggests that protease receptors and their cognate protease ligands play important roles in cell-signaling events that regulate cell adhesion and migration in inflammation as well as tumor invasion and metastasis. Tissue factor (TF), the cell surface receptor for the serine protease VIIa and the initiator of the coagulation pathways, supports metastatic implantation by activating extracellular, protease-dependent signaling pathways and by intracellular links to the actin cytoskeleton. The adhesion of TF-expressing tumor cells can be mediated by interactions of the receptor-protease complex with specific matrix-associated inhibitors, suggesting a novel bridging mechanism by which proteases participate in migratory functions of cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852129     DOI: 10.1385/IR:36:1:289

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  11 in total

Review 1.  How the protease thrombin talks to cells.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  Tissue factor signaling.

Authors:  W Ruf; B M Mueller
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

3.  P-selectin induces the expression of tissue factor on monocytes.

Authors:  A Celi; G Pellegrini; R Lorenzet; A De Blasi; N Ready; B C Furie; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 4.  Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.

Authors:  M Shoji; W W Hancock; K Abe; C Micko; K A Casper; R M Baine; J N Wilcox; I Danave; D L Dillehay; E Matthews; J Contrino; J H Morrissey; S Gordon; T S Edgington; B Kudryk; D L Kreutzer; F R Rickles
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.

Authors:  E G Fischer; M Riewald; H Y Huang; Y Miyagi; Y Kubota; B M Mueller; W Ruf
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 6.  Biology and biochemistry of proteinases in tumor invasion.

Authors:  P Mignatti; D B Rifkin
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

Review 7.  Structural biology of tissue factor, the initiator of thrombogenesis in vivo.

Authors:  W Ruf; T S Edgington
Journal:  FASEB J       Date:  1994-04-01       Impact factor: 5.191

8.  Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.

Authors:  B M Mueller; W Ruf
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

9.  Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.

Authors:  B M Mueller; R A Reisfeld; T S Edgington; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280.

Authors:  I Ott; E G Fischer; Y Miyagi; B M Mueller; W Ruf
Journal:  J Cell Biol       Date:  1998-03-09       Impact factor: 10.539

View more
  9 in total

Review 1.  The hemostatic system and angiogenesis in malignancy.

Authors:  M Z Wojtukiewicz; E Sierko; P Klement; J Rak
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

Review 2.  Interdependent biological systems, multi-functional molecules: the evolving role of tissue factor pathway inhibitor beyond anti-coagulation.

Authors:  Eric W Holroyd; Robert D Simari
Journal:  Thromb Res       Date:  2010-02-24       Impact factor: 3.944

3.  HIV envelope gp120 activates human arterial smooth muscle cells.

Authors:  A D Schecter; A B Berman; L Yi; A Mosoian; C M McManus; J W Berman; M E Klotman; M B Taubman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

4.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.

Authors:  Chloe C Milsom; Joanne L Yu; Nigel Mackman; Johann Micallef; G Mark Anderson; Abhijit Guha; Janusz W Rak
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients.

Authors:  Andrea L Small-Howard; Holden Harris
Journal:  J Immunoassay Immunochem       Date:  2010

Review 6.  Venous thromboembolism in malignant gliomas.

Authors:  E O Jenkins; D Schiff; N Mackman; N S Key
Journal:  J Thromb Haemost       Date:  2009-11-13       Impact factor: 5.824

Review 7.  Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure.

Authors:  Eric W Holroyd; Thomas A White; Shuchong Pan; Robert D Simari
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

8.  Tissue factor expression in human pterygium.

Authors:  Ryo Ando; Satoru Kase; Tsutomu Ohashi; Zhenyu Dong; Junichi Fukuhara; Atsuhiro Kanda; Miyuki Murata; Kousuke Noda; Nobuyoshi Kitaichi; Susumu Ishida
Journal:  Mol Vis       Date:  2011-01-08       Impact factor: 2.367

9.  The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis.

Authors:  Hussein Echrish; Leigh A Madden; John Greenman; Anthony Maraveyas
Journal:  Cancers (Basel)       Date:  2011-01-11       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.